Jazz Pharmaceuticals plc
JAZZ
DELAYED 1 MONTH

17 insider filings · Latest: Jun 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 3 9:09 PMBruce C CozaddDirector
Sale
6,000$235.12$1.4M372,682(D)

View →

May 28, 2026Jun 1 8:09 PMNeena M PatilEVP & Chief Legal Officer
Sale
1,192$236.97$282.5K52,626(D)

View →

May 28, 2026Jun 1 8:06 PMSamantha PearceEVP, Chief Commercial Officer
Sale
6,907$235.41$1.6M50,272(D)

View →

May 22, 2026May 27 10:13 PMRick E WinninghamDirector
Sale
2,741$241.57$662.1K9,567(D)

View →

May 22, 2026May 27 10:07 PMHeather Ann McsharryDirector
Sale
2,000$241.00$482.0K18,449(D)

View →

May 1, 2026May 5 8:27 PMBruce C CozaddDirector
Sale
6,000$203.33$1.2M378,682(D)

View →

Mar 9, 2026Mar 9 9:15 PMPatricia CarrSVP, Chief Accounting Officer
Sale
1,287$182.94$235.4K6,512(D)

View →

Mar 3, 2026Mar 4 9:24 PMBruce C CozaddDirector
Sale
6,000$186.44$1.1M405,796(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 28, 2026Jun 1 8:06 PMSamantha PearceEVP, Chief Commercial Officer
Option Exercise
6,907$109.450(D)

View →

May 28, 2026Jun 1 8:01 PMSeamus MulliganDirector
Option Exercise
3,415$138.080(D)

View →

May 22, 2026May 27 10:13 PMRick E WinninghamDirector
Option Exercise
3,415$138.080(D)

View →